These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 537830)

  • 1. Growth regulators in connective tissues. II. Evidence for the presence of several growth inhibitors in aortic extracts.
    Eisenstein R; Harper E; Kuettner KE; Schumacher B; Matijevitch B
    Paroi Arterielle; 1979 Oct; 5(3):163-9. PubMed ID: 537830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The resistance of certain tissues to invasion. III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture.
    Eisenstein R; Kuettner KE; Neapolitan C; Soble LW; Sorgente N
    Am J Pathol; 1975 Nov; 81(2):337-48. PubMed ID: 1190292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of endothelial cell-derived growth factor (ECDGF) by heparin.
    Gajdusek CM
    J Cell Physiol; 1984 Oct; 121(1):13-21. PubMed ID: 6480707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
    Dodge AB; Lu X; D'Amore PA
    J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
    Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
    J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-like molecules as regulators of atherogenesis.
    Rosenberg RD; Fritze LM; Castellot JJ; Karnovsky MJ
    Nouv Rev Fr Hematol (1978); 1984; 26(4):255-60. PubMed ID: 6473095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice.
    Eisenstein R; Schumacher B; Meineke C; Matijevitch B; Kuettner KE
    Am J Pathol; 1978 Apr; 91(1):1-9. PubMed ID: 645813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell proliferation and protease activity by cartilage factors and heparin.
    Hatcher VB; Tsien G; Oberman MS; Burk PG
    J Supramol Struct; 1980; 14(1):33-46. PubMed ID: 7012450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth modulation and proteoglycan turnover in cultured mesangial cells.
    Wang A; Fan MY; Templeton DM
    J Cell Physiol; 1994 May; 159(2):295-310. PubMed ID: 8163569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative variability of endothelial clones derived from adult bovine aorta: influence of fibroblast growth factor and smooth muscle cell extracellular matrix.
    Longenecker JP; Kilty LA; Ridge JA; Miller DC; Johnson LK
    J Cell Physiol; 1983 Jan; 114(1):7-15. PubMed ID: 6219118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    Majack RA; Clowes AW
    J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
    Forsten KE; Courant NA; Nugent MA
    J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
    Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
    Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
    Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
    J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
    Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
    Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
    Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
    J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycans in pathological conditions: atherosclerosis.
    Wight TN
    Fed Proc; 1985 Feb; 44(2):381-5. PubMed ID: 3881292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.